The global vitro diagnostics market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The growth of this market is driven by factors such as increasing prevalence of chronic diseases and rising demand for personalized medicine.
The test equipment segment accounted for the largest share in the global vitro diagnostics market in 2018, followed by test reagents and application segments. The test equipment segment is expected to continue its dominance throughout the forecast period due to increasing adoption of automated testing systems and growing demand for point-of-care testing devices.
The genetic testing segment accounted for the largest share in the global vitro diagnostics market in 2018, followed by haematology, histology and cytology, immuno chemistry, infectious diagnostics and microbiology culture segments respectively. The genetic testing segment is expected to continue its dominance throughout the forecast period due to increasing adoption of next generation sequencing technologies which are used extensively in molecular diagnostic tests such as gene sequencing or whole genome sequencing (WGS).
- Increasing awareness about the benefits of early diagnosis and treatment are also driving the growth of this market.
- Technological advancements in medical devices are expected to fuel growth in this market.
- Growing adoption of point-of-care testing (POCT) devices will also drive growth in this market.
- Increasing government funding for research and development activities will provide opportunities for companies operating in this industry.
Industry Growth Insights published a new data on “Vitro Diagnostics (IVD) Market”. The research report is titled “Vitro Diagnostics (IVD) Market research by Types (Test Equipment, Test Reagents), By Applications (Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics, Microbiology Culture), By Players/Companies Roche, SIEMENS, Danaher, Abbott, Thermo Fisher, BD, Abbott, Sysmex, BioMérieux’s, Johnson and Johnson, Bio-rad, Hologic, KHB”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Vitro Diagnostics (IVD) Market Research Report
By Type
Test Equipment, Test Reagents
By Application
Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics, Microbiology Culture
By Companies
Roche, SIEMENS, Danaher, Abbott, Thermo Fisher, BD, Abbott, Sysmex, BioMérieux’s, Johnson and Johnson, Bio-rad, Hologic, KHB
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
242
Number of Tables & Figures
170
Customization Available
Yes, the report can be customized as per your need.
 Industry Outlook.svg)
Global Vitro Diagnostics (IVD) Market Report Segments:
The global Vitro Diagnostics (IVD) market is segmented on the basis of:
Types
Test Equipment, Test Reagents
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics, Microbiology Culture
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Roche
- SIEMENS
- Danaher
- Abbott
- Thermo Fisher
- BD
- Abbott
- Sysmex
- BioMérieux’s
- Johnson and Johnson
- Bio-rad
- Hologic
- KHB
 Market Overview.svg)
Highlights of The Vitro Diagnostics (IVD) Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Test Equipment
- Test Reagents
- By Application:
- Genetic Testing
- Haematology
- Histology and Cytology
- Immuno Chemistry
- Infectious Diagnostics
- Microbiology Culture
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Vitro Diagnostics (IVD) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Vitro Diagnostics is a global medical technology company that provides innovative diagnostic solutions for the healthcare industry. The company's products include point-of-care (POC) diagnostics, laboratory services, and patient management software. Vitro Diagnostics' POC diagnostics products are used to screen for diseases and conditions such as cancer, heart disease, diabetes, and more. The company also offers laboratory services that include testing of blood samples and tissue specimens. Vitro Diagnostics' patient management software helps clinicians manage patients' care by tracking their health data across multiple settings such as hospitals, clinics, pharmacies, home health agencies etc.
Some of the key players operating in the vitro diagnostics (ivd) market are Roche, SIEMENS, Danaher, Abbott, Thermo Fisher, BD, Abbott, Sysmex, BioMƒÂ©rieux¢â‚¬â„¢s, Johnson and Johnson, Bio-rad, Hologic, KHB.
The vitro diagnostics (ivd) market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Vitro Diagnostics (IVD) Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Vitro Diagnostics (IVD) Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Vitro Diagnostics (IVD) Market - Supply Chain
4.5. Global Vitro Diagnostics (IVD) Market Forecast
4.5.1. Vitro Diagnostics (IVD) Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Vitro Diagnostics (IVD) Market Size (000 Units) and Y-o-Y Growth
4.5.3. Vitro Diagnostics (IVD) Market Absolute $ Opportunity
5. Global Vitro Diagnostics (IVD) Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Vitro Diagnostics (IVD) Market Size and Volume Forecast by Type
5.3.1. Test Equipment
5.3.2. Test Reagents
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Vitro Diagnostics (IVD) Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Vitro Diagnostics (IVD) Market Size and Volume Forecast by Application
6.3.1. Genetic Testing
6.3.2. Haematology
6.3.3. Histology and Cytology
6.3.4. Immuno Chemistry
6.3.5. Infectious Diagnostics
6.3.6. Microbiology Culture
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Vitro Diagnostics (IVD) Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Vitro Diagnostics (IVD) Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Vitro Diagnostics (IVD) Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Vitro Diagnostics (IVD) Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Vitro Diagnostics (IVD) Demand Share Forecast, 2019-2026
9. North America Vitro Diagnostics (IVD) Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Vitro Diagnostics (IVD) Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Vitro Diagnostics (IVD) Market Size and Volume Forecast by Application
9.4.1. Genetic Testing
9.4.2. Haematology
9.4.3. Histology and Cytology
9.4.4. Immuno Chemistry
9.4.5. Infectious Diagnostics
9.4.6. Microbiology Culture
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Vitro Diagnostics (IVD) Market Size and Volume Forecast by Type
9.7.1. Test Equipment
9.7.2. Test Reagents
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Vitro Diagnostics (IVD) Demand Share Forecast, 2019-2026
10. Latin America Vitro Diagnostics (IVD) Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Vitro Diagnostics (IVD) Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Vitro Diagnostics (IVD) Market Size and Volume Forecast by Application
10.4.1. Genetic Testing
10.4.2. Haematology
10.4.3. Histology and Cytology
10.4.4. Immuno Chemistry
10.4.5. Infectious Diagnostics
10.4.6. Microbiology Culture
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Vitro Diagnostics (IVD) Market Size and Volume Forecast by Type
10.7.1. Test Equipment
10.7.2. Test Reagents
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Vitro Diagnostics (IVD) Demand Share Forecast, 2019-2026
11. Europe Vitro Diagnostics (IVD) Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Vitro Diagnostics (IVD) Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Vitro Diagnostics (IVD) Market Size and Volume Forecast by Application
11.4.1. Genetic Testing
11.4.2. Haematology
11.4.3. Histology and Cytology
11.4.4. Immuno Chemistry
11.4.5. Infectious Diagnostics
11.4.6. Microbiology Culture
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Vitro Diagnostics (IVD) Market Size and Volume Forecast by Type
11.7.1. Test Equipment
11.7.2. Test Reagents
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Vitro Diagnostics (IVD) Demand Share, 2019-2026
12. Asia Pacific Vitro Diagnostics (IVD) Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Vitro Diagnostics (IVD) Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Vitro Diagnostics (IVD) Market Size and Volume Forecast by Application
12.4.1. Genetic Testing
12.4.2. Haematology
12.4.3. Histology and Cytology
12.4.4. Immuno Chemistry
12.4.5. Infectious Diagnostics
12.4.6. Microbiology Culture
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Vitro Diagnostics (IVD) Market Size and Volume Forecast by Type
12.7.1. Test Equipment
12.7.2. Test Reagents
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Vitro Diagnostics (IVD) Demand Share, 2019-2026
13. Middle East & Africa Vitro Diagnostics (IVD) Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Vitro Diagnostics (IVD) Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Vitro Diagnostics (IVD) Market Size and Volume Forecast by Application
13.4.1. Genetic Testing
13.4.2. Haematology
13.4.3. Histology and Cytology
13.4.4. Immuno Chemistry
13.4.5. Infectious Diagnostics
13.4.6. Microbiology Culture
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Vitro Diagnostics (IVD) Market Size and Volume Forecast by Type
13.7.1. Test Equipment
13.7.2. Test Reagents
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Vitro Diagnostics (IVD) Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Vitro Diagnostics (IVD) Market: Market Share Analysis
14.2. Vitro Diagnostics (IVD) Distributors and Customers
14.3. Vitro Diagnostics (IVD) Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Roche
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. SIEMENS
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Danaher
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Abbott
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Thermo Fisher
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. BD
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Abbott
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Sysmex
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. BioMérieuxs
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Johnson and Johnson
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Bio-rad
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Hologic
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. KHB
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
